Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 15, 2026

Growth Assays to Assess Polyglutamine Toxicity in Yeast
09:06

Growth Assays to Assess Polyglutamine Toxicity in Yeast

Published on: March 5, 2012

Polyglutamine toxicity in non-neuronal cells.

Jennifer W Bradford1, Shihua Li, Xiao-Jiang Li

  • 1Department of Human Genetics, Emory University School of Medicine, Atlanta, GA 30322, USA.

Cell Research
|March 17, 2010
PubMed
Summary

Polyglutamine diseases, like Huntington's, affect brain cells. New research shows these diseases also impact non-neuronal cells, influencing neurological symptoms and disease progression.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Focusing on inflammation-driven pyroptosis in postherpetic neuralgia: from molecular mechanisms to therapeutic strategies.

Frontiers in immunology·2026
Same author

A Multi-Regional Single-nucleus Atlas of the Huntington's Disease Brain.

Scientific data·2026
Same author

Mutant huntingtin disrupts TET1 transcription and alters DNA methylation in a Huntington's disease knock-in pig model.

Cell reports·2026
Same author

Pyraclostrobin triggers pulmonary inflammation, oxidative stress, and fibrosis in mouse via Wnt/β-catenin signaling.

Chemico-biological interactions·2026
Same author

Caspase-4 transgenic mice exhibit cytoplasmic TDP-43 accumulation and age-dependent neuropathology.

Nature communications·2026
Same author

Transient efferocytosis-induced activation of IKKβ reprograms macrophages to promote tissue resolution.

bioRxiv : the preprint server for biology·2026

Area of Science:

  • Neuroscience
  • Genetics
  • Cell Biology

Background:

  • Neurodegenerative polyglutamine diseases stem from expanded polyglutamine (PolyQ) repeats in proteins.
  • These mutant PolyQ proteins are found in both neuronal and non-neuronal cells, yet primarily cause selective neuronal degeneration.
  • The role of PolyQ protein expression in non-neuronal cells remains poorly understood.

Purpose of the Study:

  • To review recent findings on mutant polyglutamine protein expression in non-neuronal cells.
  • To explore the influence of non-neuronal PolyQ proteins on neurological symptoms.
  • To highlight the importance of non-neuronal cells in understanding polyglutamine disease mechanisms.

Main Methods:

  • Literature review of recent studies on polyglutamine diseases.
  • Analysis of evidence regarding mutant polyglutamine protein expression in non-neuronal tissues.
  • Synthesis of findings on the correlation between non-neuronal PolyQ protein presence and neurological symptoms.

Main Results:

  • Growing evidence indicates that polyglutamine disease proteins are expressed in non-neuronal cells.
  • The presence and function of these proteins in non-neuronal cells appear to influence the manifestation and progression of neurological symptoms.
  • Non-neuronal cells are increasingly recognized as significant contributors to the overall disease course.

Conclusions:

  • Mutant polyglutamine proteins in non-neuronal cells play a crucial role in polyglutamine disease pathogenesis.
  • Understanding the contribution of non-neuronal cells is vital for a comprehensive grasp of these neurodegenerative conditions.
  • Targeting non-neuronal PolyQ protein effects may offer novel therapeutic strategies for polyglutamine diseases.

More Related Videos

Caenorhabditis elegans as a Model System for Discovering Bioactive Compounds Against Polyglutamine-Mediated Neurotoxicity
08:16

Caenorhabditis elegans as a Model System for Discovering Bioactive Compounds Against Polyglutamine-Mediated Neurotoxicity

Published on: September 21, 2021

Assays for the Degradation of Misfolded Proteins in Cells
10:56

Assays for the Degradation of Misfolded Proteins in Cells

Published on: August 28, 2016

Related Experiment Videos

Last Updated: Jun 15, 2026

Growth Assays to Assess Polyglutamine Toxicity in Yeast
09:06

Growth Assays to Assess Polyglutamine Toxicity in Yeast

Published on: March 5, 2012

Caenorhabditis elegans as a Model System for Discovering Bioactive Compounds Against Polyglutamine-Mediated Neurotoxicity
08:16

Caenorhabditis elegans as a Model System for Discovering Bioactive Compounds Against Polyglutamine-Mediated Neurotoxicity

Published on: September 21, 2021

Assays for the Degradation of Misfolded Proteins in Cells
10:56

Assays for the Degradation of Misfolded Proteins in Cells

Published on: August 28, 2016